Company
Overview
Management Team
Vision & Values
History
Photo Gallery
Gene Therapy
AAV Gene Therapy
Vector Optimization
Manufacturing
Quality Assurance
Pipeline
ICM-203
ICM-502
ICM-322
ICM-403
Glossary
Investors
Investors
Newsroom
Press Release
Careers & Contact
Recruit
Location & Contact
Eng
한국어
Eng
한국어
News
Information
ICM pursues novel therapeutic solutions
for incurable diseases.
Company
Press Release
No.
Title
Name
Date
View
16
57 Projects Selected in the First Round of the Korea Drug Development Fund Program…KRW 112.8 Billion in Funding Over Two Years (2026.05.13)
관리자
2026-09-10
View수 :
10
15
Regeneron Reports First Case of Hearing Restoration in a Patient with Genetic Hearing Loss… Lilly and ICM Accelerate Development Efforts (2024.05.17)
관리자
2026-09-10
View수 :
9
14
ICM Selected as an “Outstanding Bio Company” (2024.04.08)
관리자
2026-09-10
View수 :
7
13
ICM’s Hearing Loss Treatment Demonstrates Efficacy in Animal Studies (2023.08.22)
관리자
2026-09-10
View수 :
7
12
Stem Cells and Exosomes…K-Bio Heats Up Race to Develop Osteoarthritis Treatments (2023.02.21)
관리자
2026-09-10
View수 :
8
11
ICM Targets U.S. Clinical Trial Entry for Osteoarthritis Gene Therapy by Year-End (2022.07.11)
관리자
2026-09-10
View수 :
9
10
When a Researcher with 20 Years of Dedication Meets a Developer Who Has Experienced Both Success and Failure (2022.05.25)
관리자
2026-09-10
View수 :
7
9
Aiming to Develop the World’s First Cartilage-Regenerating Osteoarthritis Treatment Through Gene Therapy (2022.04.07)
관리자
2026-09-10
View수 :
9
8
Despite KRW 30 Trillion in Failed Investments, Why LG, Medipost, and ICM Are Drawing Attention (2021.12.20)
관리자
2026-09-10
View수 :
8
7
ICM to Begin U.S. Clinical Trial of Osteoarthritis Treatment in First Half of Next Year (2021.12.06)
관리자
2026-09-10
View수 :
6
6
ICM: “Cartilage-Regenerating Treatment Is Becoming a Reality, Not Just a Dream” (2021.06.11)
관리자
2026-09-10
View수 :
9
5
Aiming to Develop the World’s First DMOAD for Osteoarthritis (2020.12.30)
관리자
2026-09-10
View수 :
9
4
LG Chem Licenses Osteoarthritis Drug Candidate from Biotech Venture ICM (2020.12.22)
관리자
2026-09-10
View수 :
7
3
Yonsei University Technology Holdings Newsletter (2020.08.27)
관리자
2026-09-10
View수 :
7
2
ICM, a Subsidiary of Yonsei University Technology Holdings, Plans IPO Next Year (2020.02.17)
관리자
2026-09-10
View수 :
14
1
Biotech Company ICM Secures Investment from Three VCs (2017.07.05)
관리자
2026-09-10
View수 :
11
Title
Name
Content
<
1
>